SCHEMBL18540682

SCHEMBL18540682

Cc1ccccc1-n1c2ccccc2c2cc(Br)ccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSPO P30536 2/20 0.44
CASP3 P42574 1/20 0.42
TSHR P16473 1/20 0.41
MEN1 O00255 1/20 0.39
RAD52 P43351 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
RAB9A P51151 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
LMNA P02545 1/20 0.38
ALKBH5 Q6P6C2 1/20 0.38
FTO Q9C0B1 1/20 0.38
MAPT P10636 2/20 0.37
TP53 P04637 1/20 0.37
ACHE P22303 2/20 0.37
BCHE P06276 1/20 0.37
KDM4E B2RXH2 1/20 0.36
ATM Q13315 1/20 0.36
PTGER4 P35408 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3299162 0.95 CASP3 (0.45) TSPOCASP3TSHRKMT2AALDH1A1
SCHEMBL27120040 0.90 TSHR (0.41) TSPOCASP3TSHRALDH1A1SMN1; SMN2
SCHEMBL30159243 0.89 TSPO (0.41) TSPOCASP3TSHRMEN1RAD52
SCHEMBL21636110 0.85 ALDH1A1 (0.47) CASP3ALDH1A1SMN1; SMN2RAB9AL3MBTL1
SCHEMBL19269510 0.85 ACHE (0.40) TSPOTSHRMEN1KMT2AALDH1A1
SCHEMBL6570705 0.84 TSHR (0.47) TSHRKMT2AALDH1A1SMN1; SMN2RAB9A
SCHEMBL6552455 0.84 TSHR (0.53) TSHRALDH1A1SMN1; SMN2RAB9AL3MBTL1
SCHEMBL17166722 0.83 TSHR (0.44) TSHRALDH1A1SMN1; SMN2RAB9AL3MBTL1
SCHEMBL11926711 0.83 JAK2 (0.38) TSPOCASP3TSHRMEN1KMT2A
SCHEMBL28393607 0.81 MAPT (0.42) TSPOTSHRMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112010798-A Method for synthesizing N-arylcarbazole compound by catalyzing reaction of carbazole and arylhydrazine with transition metal 新乡市润宇新材料科技有限公司 2020-12-01 CN disclosed
US-20170213984-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME LG CHEM, LTD. (KR) 2017-07-27 US disclosed
US-20170054083-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170213984-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME CRY1, NOS1, NOLC1 TSPO 3976/4885CASP3 3750/4885TSHR 4646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.